News

ctDNA testing paper

Posted 29/04/2019

Latest GenQA publication, as part of IQNPath, on clinical ctDNA testing. To read the paper go to: https://lnkd.in/gibwaA6

Tumour Mutation Burden (TMB) testing project

Posted 24/04/2019

IQNPath, with the endorsement of ESMO, is conducting a project on tumour mutation burden (TMB) testing. The primary aim of this project is to organize a pilot External Quality Assessment (EQA) scheme for TMB assessment.  We are currently working to identify appropriate reference materials which will then be validated by a cohort of laboratories.

We are recruiting 30 laboratories to participate in the pilot EQA scheme.  If you are interested in participating, please complete the IQN Survey by the 10th May.  This will be used to identify laboratories that meet the requirements of the pilot.

Educational Rapid Aneuploidy Prenatal Testing (QF-PCR) Workshop

Posted 23/04/2019

The next GenQA educational workshop is happening on 17th June at ESHG:

'Rapid Aneuploidy Prenatal Testing (QF-PCR)'

For further details see HERE

 

Brexit Preparations

Posted 22/03/2019

Please find details of GenQA's preparations for a no deal Brexit HERE

 

Latest GenQA publication

Posted 18/03/2019

Published in Prenatal Diagnosis, February 2019: Ensuring High Standards for the Delivery of NIPT World-Wide 

Healthcare Scientist of the Year Award

Posted 8/03/2019

Congratulations to Dr Sandi Deans (Director of GenQA) for receiving the Healthcare Scientist of the Year award award from Genomics England and NHS England!

PGT SAG Members - Vacancies

Posted 11/02/2019

The GenQA Specialist Advisory Group for Preimplantation Genetic Testing has opened applications to members of the genomics profession with expertise in all aspects of PGT (e.g. clinicians, embryologists, scientists etc). 

For further details please see the advert here: Advert for PGT SAG members 2019 v1.pdf

BRCA in Ovarian Cancer EQA for 2019

Posted 14/01/2019

GenQA and EMQN are collaborating to deliver two different BRCA Ovarian Cancer schemes; one for Germline mutation testing and another for Somatic mutation testing. 

For more information on the content and how to register see: GenQA EMQN BRCA in Ovarian Cancer EQA 2019.pdf

 

Non-conformities during routine biomarker testing for lung and colon cancer

Posted 13/12/2018

Dear colleague, 
You are invited to participate in a study to evaluate the frequency of non-conformities during routine biomarker testing for lung and colon cancer.  The aim of this study is to benchmark different non-conformities between institutes in the UK, and to compare them with data that has already been collected from other European institutes. 

All data will be handled anonymously and will be included in a Biomedical Science final year project and a further PhD thesis, as a joint initiative between the University of Leuven in Belgium under the supervision of Prof. Dequeker and the Queen Elizabeth Hospital Birmingham (QEHB), UK under the supervision of Mr. Brendan O'Sullivan.

It would be much appreciated if you could further forward this invitation to others who may be interested in doing so.  The completion of the questionnaire will take no more than 15 minutes.   To start the survey please CLICK HERE

We hope that we can gather representative data from all over the UK and would greatly appreciate it if you would take part in this study. Please do not hesitate to contact us with any questions you might have.

Thank you in advance:
Yann van Royen, Biomedical Science student at University of Leuven, Belgium
Mr. Brendan O'Sullivan, Operations Manager in Molecular Pathology at QEHB
Dr. Philippe Taniere, Consultant Histopathologist at QEHB
Cleo Keppens, PhD student,Biomedical Quality Assurance Research Unit at KU Leuven Belgium
Prof Dequeker, Head of Biomedical Quality Assurance Research Unit at KU Leuven Belgium 

List of GenQA publications

Posted 5/12/2018

For our latest publications go to https://www.genqa.org/publications

Pages

Go to top